These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9156046)

  • 21. Serum ghrelin levels are suppressed in hypopituitary patients following insulin-induced hypoglycaemia irrespective of GH status.
    Ryber L; Obrink K; Houe N; Frystyk J; Jørgensen JO
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):210-4. PubMed ID: 16886962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophin-releasing hormone, arginine vasopressin and adrenocorticotrophin in horses.
    Alexander SL; Roud HK; Irvine CH
    J Endocrinol; 1997 Jun; 153(3):401-9. PubMed ID: 9203994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luteinizing hormone responses to luteinizing hormone releasing hormone, and growth hormone and cortisol responses to insulin induced hypoglycaemia in functional secondary amenorrhoea.
    Hirvonen E; Seppälä M; Karonen SL; Adlercreutz H
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):225-36. PubMed ID: 319613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of obesity and weight loss on the arginine vasopressin response to insulin-induced hypoglycaemia.
    Coiro V; Chiodera P
    Clin Endocrinol (Oxf); 1987 Aug; 27(2):253-8. PubMed ID: 3311483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of insulin- and proinsulin-induced hypoglycemia on pituitary hormone and catecholamine secretion.
    Williams TC; Berelowitz M; Berk MA; Frohman LA
    Diabetes Care; 1987; 10(3):278-85. PubMed ID: 3109862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of the GH responsiveness to GH releasing stimuli by lysine vasopressin in type 1 diabetic subjects.
    Coiro V; Volpi R; Capretti L; Speroni G; Caffarri G; Marchesi C; Chiodera P
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):487-95. PubMed ID: 10583317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of the hypoglycaemic clamp in the assessment of pituitary function.
    Semakula C; Damberg G; Kendall D; Seaquist ER
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):709-14. PubMed ID: 10619975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
    Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
    Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.
    Pal BR; Matthews DR; Edge JA; Mullis PE; Hindmarsh PC; Dunger DB
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):93-100. PubMed ID: 8435890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
    Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R
    J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus.
    Clayton KL; Holly JM; Carlsson LM; Jones J; Cheetham TD; Taylor AM; Dunger DB
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):517-24. PubMed ID: 7955462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone and growth in diabetic rats: effects of insulin and insulin-like growth factor-I infusions.
    Carlsson LM; Clark RG; Skottner A; Robinson IC
    J Endocrinol; 1989 Sep; 122(3):661-70. PubMed ID: 2681500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats.
    Katoh K; Yoshida M; Kobayashi Y; Onodera M; Kogusa K; Obara Y
    J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control.
    Kinsley BT; Widom B; Utzschneider K; Simonson DC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1383-9. PubMed ID: 7962332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replacement therapy: arginine vasopressin (AVP), growth hormone (GH), cortisol, thyroxine, testosterone and estrogen.
    Mitchell DH; Owens B
    J Neurosci Nurs; 1996 Jun; 28(3):140-52; quiz 152-4. PubMed ID: 8818980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin and beta-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus.
    Kinsley BT; Levy CJ; Simonson DC
    Metabolism; 1996 Nov; 45(11):1434-40. PubMed ID: 8931651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.